Healthcare provider profile · identity verified

John D Powell, M.D.

Family Practice · LENOIR, NC · NPI 1578591988

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	736	209
Omeprazole	Omeprazole	365	97
Levothyroxine Sodium	Levothyroxine Sodium	353	92
Amlodipine Besylate	Amlodipine Besylate	319	93
Lisinopril	Lisinopril	310	80
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	275	40
Metformin Hcl	Metformin Hcl	269	76
Hydrochlorothiazide	Hydrochlorothiazide	234	65
Gabapentin	Gabapentin	215	65
Metoprolol Succinate	Metoprolol Succinate	209	57
Tramadol Hcl	Tramadol Hcl	196	30
Duloxetine Hcl	Duloxetine Hcl	195	52
Losartan Potassium	Losartan Potassium	169	46
Rosuvastatin Calcium	Rosuvastatin Calcium	162	51
Pantoprazole Sodium	Pantoprazole Sodium	161	53
Alprazolam	Alprazolam	157	26
Valsartan	Valsartan	151	47
Allopurinol	Allopurinol	148	40
Potassium Chloride	Potassium Chloride	147	50
Pioglitazone Hcl	Pioglitazone Hcl	143	35
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	125	12
Furosemide	Furosemide	120	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	118	36
Ozempic	Semaglutide	116	17
Montelukast Sodium	Montelukast Sodium	114	31
Alendronate Sodium	Alendronate Sodium	106	35
Tamsulosin Hcl	Tamsulosin Hcl	105	31
Albuterol Sulfate Hfa	Albuterol Sulfate	104	44
Pravastatin Sodium	Pravastatin Sodium	103	31
Metoprolol Tartrate	Metoprolol Tartrate	100	29
Zolpidem Tartrate	Zolpidem Tartrate	99	18
Clonazepam	Clonazepam	89	14
Eliquis	Apixaban	89	25
Clopidogrel	Clopidogrel Bisulfate	88	25
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	87	22
Trazodone Hcl	Trazodone Hcl	86	28
Fluticasone Propionate	Fluticasone Propionate	83	33
Soliqua 100-33	Insulin Glargine/Lixisenatide	83	16
Bupropion Xl	Bupropion Hcl	77	20
Lorazepam	Lorazepam	77	14
Fluoxetine Hcl	Fluoxetine Hcl	76	20
Carvedilol	Carvedilol	73	20
Simvastatin	Simvastatin	73	19
Jardiance	Empagliflozin	72	19
Famotidine	Famotidine	70	19
Glipizide	Glipizide	69	17
Ropinirole Hcl	Ropinirole Hcl	68	20
Celecoxib	Celecoxib	66	30
Buspirone Hcl	Buspirone Hcl	65	18
Pregabalin	Pregabalin	60	15
Oxycodone Hcl	Oxycodone Hcl	58	suppressed
Warfarin Sodium	Warfarin Sodium	58	11
Sertraline Hcl	Sertraline Hcl	55	24
Donepezil Hcl	Donepezil Hcl	54	14
Xarelto	Rivaroxaban	54	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	53	suppressed
Farxiga	Dapagliflozin Propanediol	53	13
Quetiapine Fumarate	Quetiapine Fumarate	53	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	16
Spironolactone	Spironolactone	47	13
Trulicity	Dulaglutide	47	suppressed
Glimepiride	Glimepiride	46	14
Meloxicam	Meloxicam	46	17
Escitalopram Oxalate	Escitalopram Oxalate	45	13
Promethazine Hcl	Promethazine Hcl	45	suppressed
Tizanidine Hcl	Tizanidine Hcl	42	16
Aripiprazole	Aripiprazole	41	suppressed
Ondansetron Hcl	Ondansetron Hcl	41	15
Lovastatin	Lovastatin	39	11
Ezetimibe	Ezetimibe	36	13
Meclizine Hcl	Meclizine Hcl	35	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Diazepam	Diazepam	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Mounjaro	Tirzepatide	32	suppressed
Topiramate	Topiramate	32	suppressed
Metformin Hcl Er	Metformin Hcl	30	suppressed
Baclofen	Baclofen	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Finasteride	Finasteride	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Kerendia	Finerenone	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	18
Tresiba Flextouch U-200	Insulin Degludec	27	suppressed
Klor-Con M20	Potassium Chloride	26	suppressed
Olanzapine	Olanzapine	26	suppressed
Prednisone	Prednisone	26	15
Levetiracetam	Levetiracetam	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	22
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	23	suppressed
Sucralfate	Sucralfate	22	suppressed
Divalproex Sodium	Divalproex Sodium	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	20	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Atenolol	Atenolol	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Klor-Con M10	Potassium Chloride	18	suppressed
Ramipril	Ramipril	18	suppressed
Cefdinir	Cefdinir	17	suppressed
Cephalexin	Cephalexin	17	11
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Naproxen	Naproxen	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Invokana	Canagliflozin	15	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Testosterone	Testosterone	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	12
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Clozapine	Clozapine	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Clonidine	Clonidine	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error